Health economic consequences of the pharmacological treatment of heart failure.

@article{Cleland1998HealthEC,
  title={Health economic consequences of the pharmacological treatment of heart failure.},
  author={John Gf Cleland},
  journal={European heart journal},
  year={1998},
  volume={19 Suppl P},
  pages={P32-9}
}
Health economics is about spending limited resources wisely and, as with so many fields in medicine, combines science with art and ingenuity. In order to know whether money is well spent it is necessary to have some reference points to make comparisons. Many accepted cardiovascular interventions, such as revascularization for multivessel disease (US$50000 per life year gained) or the use of a statin for hypercholesterolaemia in middle-aged men at high risk of cardiovascular events (US$30000 per… CONTINUE READING